CN111228490B - 一种钙磷复合多孔纳米碳纤维光热试剂的制备方法 - Google Patents
一种钙磷复合多孔纳米碳纤维光热试剂的制备方法 Download PDFInfo
- Publication number
- CN111228490B CN111228490B CN202010114673.5A CN202010114673A CN111228490B CN 111228490 B CN111228490 B CN 111228490B CN 202010114673 A CN202010114673 A CN 202010114673A CN 111228490 B CN111228490 B CN 111228490B
- Authority
- CN
- China
- Prior art keywords
- porous carbon
- calcium
- preparation
- carbon nanofiber
- photothermal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002133 porous carbon nanofiber Substances 0.000 title claims abstract description 47
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- ZQBZAOZWBKABNC-UHFFFAOYSA-N [P].[Ca] Chemical compound [P].[Ca] ZQBZAOZWBKABNC-UHFFFAOYSA-N 0.000 title claims abstract description 18
- 239000002131 composite material Substances 0.000 title claims abstract description 18
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 21
- 239000004917 carbon fiber Substances 0.000 claims abstract description 20
- 238000006243 chemical reaction Methods 0.000 claims abstract description 13
- 230000000694 effects Effects 0.000 claims abstract description 10
- 230000005764 inhibitory process Effects 0.000 claims abstract description 10
- 230000002195 synergetic effect Effects 0.000 claims abstract description 7
- 210000004881 tumor cell Anatomy 0.000 claims abstract description 6
- 238000001338 self-assembly Methods 0.000 claims abstract description 5
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical class C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 43
- 239000000243 solution Substances 0.000 claims description 25
- 239000002134 carbon nanofiber Substances 0.000 claims description 24
- 239000011575 calcium Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- 229920000049 Carbon (fiber) Polymers 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 19
- 238000004140 cleaning Methods 0.000 claims description 15
- 229910021392 nanocarbon Inorganic materials 0.000 claims description 15
- 239000008367 deionised water Substances 0.000 claims description 14
- 229910021641 deionized water Inorganic materials 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
- 238000009987 spinning Methods 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000004108 freeze drying Methods 0.000 claims description 9
- 239000012221 photothermal agent Substances 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 8
- 239000006185 dispersion Substances 0.000 claims description 8
- 210000004027 cell Anatomy 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims description 6
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 6
- 238000005576 amination reaction Methods 0.000 claims description 6
- 238000003763 carbonization Methods 0.000 claims description 6
- 238000010041 electrostatic spinning Methods 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 229910017604 nitric acid Inorganic materials 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 238000007626 photothermal therapy Methods 0.000 claims description 6
- 229920002239 polyacrylonitrile Polymers 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 229910052698 phosphorus Inorganic materials 0.000 claims description 5
- 239000011574 phosphorus Substances 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000013329 compounding Methods 0.000 claims description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 4
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 4
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 3
- 239000006087 Silane Coupling Agent Substances 0.000 claims description 3
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 3
- 230000009435 amidation Effects 0.000 claims description 3
- 238000007112 amidation reaction Methods 0.000 claims description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- 230000001640 apoptogenic effect Effects 0.000 claims description 3
- 230000024683 calcium ion homeostasis Effects 0.000 claims description 3
- 238000004113 cell culture Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000003760 magnetic stirring Methods 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 210000003470 mitochondria Anatomy 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000010000 carbonizing Methods 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims description 2
- 230000004083 survival effect Effects 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 230000006907 apoptotic process Effects 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 239000011248 coating agent Substances 0.000 abstract description 2
- 238000000576 coating method Methods 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 abstract 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 abstract 1
- 239000003575 carbonaceous material Substances 0.000 description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- AUQMGYLQQPSCNH-UHFFFAOYSA-L NIR-2 dye Chemical compound [K+].[K+].C1=CC2=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C=C2C(C2(C)C)=C1[N+](CC)=C2C=CC=CC=C1C(C)(C)C2=CC(C(O)=O)=CC=C2N1CCCCS([O-])(=O)=O AUQMGYLQQPSCNH-UHFFFAOYSA-L 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 238000002428 photodynamic therapy Methods 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F9/00—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
- D01F9/08—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments of inorganic material
- D01F9/12—Carbon filaments; Apparatus specially adapted for the manufacture thereof
- D01F9/14—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments
- D01F9/20—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from polyaddition, polycondensation or polymerisation products
- D01F9/21—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from polyaddition, polycondensation or polymerisation products from macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F9/00—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
- D01F9/08—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments of inorganic material
- D01F9/12—Carbon filaments; Apparatus specially adapted for the manufacture thereof
- D01F9/14—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments
- D01F9/20—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from polyaddition, polycondensation or polymerisation products
- D01F9/21—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from polyaddition, polycondensation or polymerisation products from macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D01F9/22—Carbon filaments; Apparatus specially adapted for the manufacture thereof by decomposition of organic filaments from polyaddition, polycondensation or polymerisation products from macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds from polyacrylonitriles
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/32—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond
- D06M11/36—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond with oxides, hydroxides or mixed oxides; with salts derived from anions with an amphoteric element-oxygen bond
- D06M11/44—Oxides or hydroxides of elements of Groups 2 or 12 of the Periodic Table; Zincates; Cadmates
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/51—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with sulfur, selenium, tellurium, polonium or compounds thereof
- D06M11/55—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with sulfur, selenium, tellurium, polonium or compounds thereof with sulfur trioxide; with sulfuric acid or thiosulfuric acid or their salts
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/58—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with nitrogen or compounds thereof, e.g. with nitrides
- D06M11/64—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with nitrogen or compounds thereof, e.g. with nitrides with nitrogen oxides; with oxyacids of nitrogen or their salts
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/68—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with phosphorus or compounds thereof, e.g. with chlorophosphonic acid or salts thereof
- D06M11/70—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with phosphorus or compounds thereof, e.g. with chlorophosphonic acid or salts thereof with oxides of phosphorus; with hypophosphorous, phosphorous or phosphoric acids or their salts
- D06M11/71—Salts of phosphoric acids
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/322—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
- D06M13/402—Amides imides, sulfamic acids
- D06M13/432—Urea, thiourea or derivatives thereof, e.g. biurets; Urea-inclusion compounds; Dicyanamides; Carbodiimides; Guanidines, e.g. dicyandiamides
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/50—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with organometallic compounds; with organic compounds containing boron, silicon, selenium or tellurium atoms
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/50—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with organometallic compounds; with organic compounds containing boron, silicon, selenium or tellurium atoms
- D06M13/51—Compounds with at least one carbon-metal or carbon-boron, carbon-silicon, carbon-selenium, or carbon-tellurium bond
- D06M13/513—Compounds with at least one carbon-metal or carbon-boron, carbon-silicon, carbon-selenium, or carbon-tellurium bond with at least one carbon-silicon bond
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/21—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/263—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds of unsaturated carboxylic acids; Salts or esters thereof
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M15/00—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment
- D06M15/19—Treating fibres, threads, yarns, fabrics, or fibrous goods made from such materials, with macromolecular compounds; Such treatment combined with mechanical treatment with synthetic macromolecular compounds
- D06M15/37—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- D06M15/53—Polyethers
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/40—Fibres of carbon
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Carbon And Carbon Compounds (AREA)
Abstract
本发明公开了一种钙磷复合多孔纳米碳纤维光热试剂的制备方法,多孔纳米碳纤维采用静电纺丝技术制得,然后对其进行共价功能修饰,提高其分散性,再进行酰胺化处理,进一步提高多孔纳米碳纤维的生物相容性。最后通过表面层层自组装反应,在其表面包覆羟基磷灰石,制得所述产品。在本发明中,对照已有技术的有益效果是,此光热试剂对于肿瘤治疗的增强属于双功能协同效应,一方面钙磷复合多孔纳米碳纤维的光热转化效率高,可以在红外光作用下,杀死肿瘤细胞;另一方面碳纤维表面Ca2+的释放同样可以导致肿瘤细胞的凋亡,因此双功能协同效应的钙磷复合多孔纳米碳纤维光热试剂具有良好的肿瘤抑制效果。
Description
技术领域
本发明涉及生物医学技术领域,具体为一种钙磷复合多孔纳米碳纤维光热试剂的制备方法。
背景技术
近年来,癌症的发病率和死亡率在世界范围内迅速增长,严重影响人类生命安全,阻碍社会发展。目前,常用的传统治疗手段如外科手术治疗,放射疗法以及化学疗法等,简单有效,但容易切除不完整,有辐射或是产生耐药性等副作用。新型治疗手段多采用微创,很大程度上减轻了患者身体负担,如生物治疗是利用自身免疫抗癌,相对于传统疗法具有较高的针对性和安全性,多适用于实体肿瘤;光动力学治疗是利用植入的光敏剂吸收可见光,产生活性氧造成细胞死亡。这种方法毒性低,疗效快但是最主要的弊端是光的毒副作用,全程需在黑暗中进行,避免健康部位接触可见光。
光热治疗作为第五大肿瘤治疗手段,是利用纳米光热试剂吸收 700nm-1100nm的近红外作为光源,将光能转化为热能,对患者病灶部加热,使肿瘤细胞或组织温度上升至有效治疗温度范围(40~46℃),诱导细胞凋亡或对细胞产生直接致死效应,在不损伤健康组织细胞的前提下,达到杀灭肿瘤的效果。该方法微创高效,毒副作用小,具有很好的光学安全性和组织渗透性。纳米碳基材料作为光热试剂在肿瘤抑制领域已有广泛的应用,但目前纳米碳基材料多采用石墨烯、碳纳米管等,价格昂贵,制备繁琐。纳米碳纤维则克服了以上缺点,它制备简单,来源广泛,目前以纳米碳纤维为碳源的相关研究还比较少。
申请号为201710412890.0的发明专利公开了一种用于肿瘤治疗的多孔纳米碳纤维基载药光热试剂及其制备方法,将表面酸化的多孔纳米碳纤维依次分散在壳聚糖和海藻酸钠溶液中,通过聚合物的层层自组形成表面修饰后的纳米碳纤维,最后分散于抗癌药物水溶液中,得到最终载药光热试剂,是以化学-光热联合治疗来提高肿瘤抑制率的方法。该发明制得的碳纤维基光热试剂为三层结构,以壳聚糖和海藻酸钠提高其分散性和生物相容性,但两者均没有光热转化能力,多层包覆会造成纳米碳纤维的光热转化效率不佳,且该纳米碳纤维基光热材料需通过载药才能达到较好的抗肿瘤效果。
发明内容
本发明的目的是在不影响或提高纳米碳材料光热转化效率的前提下克服其分散性差,低生物相容性的问题,提供一种钙磷复合多孔纳米碳纤维光热试剂的制备方法。所述试剂由表面酸化再酰胺化的多孔纳米碳纤维为基材,包覆CaP,形成壳核结构,不仅提高了纳米碳材料的分散性、生物相容性和光热转化效率,且Ca2+的释放具有PH和温度双响应效应,在近红外的照射下,发挥光热治疗与Ca2+的协同作用,提高肿瘤抑制效率。
为实现上述目的,本发明提供如下技术方案:一种钙磷复合多孔纳米碳纤维光热试剂的制备方法,包括以下步骤:
A、采用静电纺技术制备多孔纳米碳纤维:
首先,按照质量分数分别为7%-50%的聚丙烯腈,5%-10%的聚甲基丙烯酸甲酯,40%-88%的二甲基甲酰胺为基材配置纺丝溶液,60-80℃下搅拌溶融至溶液混合均匀后,进行纺丝,根据溶液的粘稠度设置不同的工艺参数,如纺丝速度0.010mL/min-0.020mL/min,纺丝喷头到接受面的距离10-20cm;
然后,将纺出的薄膜先在230-260℃环境中进行预氧化,再在700-900℃中碳化,整个过程在氮气环境中进行,将碳化后形成的多孔纳米碳纤维研磨成粉末状备用;
B、对纳米碳纤维进行表面改性时,先用浓硫酸和硝酸混合液酸化,再进行酰胺化处理;进一步提高纳米碳纤维的生物相容性和分散性,具体方法如下:
将步骤A中的多孔纳米碳纤维浸没在浓硫酸和浓硝酸(3:1)的混合液中, 60-80℃下搅拌3-5h;然后以6800-7830rpm转速离心,清洗多次,冻干。将冻干后的多孔纳米碳纤维进行氨基化处理;所述纳米碳纤维表面氨基化有如下制备方法:
1)按纳米碳纤维与PEG以1:10-30的质量比混合均匀,溶于去离子水中,再依次加入DMAP和DCC,60-80℃反应24h,离心清洗,冻干备用;
2)按纳米碳纤维与硫脲1:5-10的质量比混合均匀,放入管式碳化炉中氮气环境下80℃反应30-60min,100℃保温30min,130-178℃反应2-4h,降至室温离心清洗,冻干备用;
3)将CTAB和NaOH溶解在去离子水中,70-90℃搅拌1-2h,加入多孔纳米碳纤维、缓慢滴加TEOS和硅烷偶联剂KH550,80℃下搅拌1-3h,离心清洗,分散在稀盐酸溶液中,搅拌24h,再次离心清洗,冻干备用;
C、表面氨基化的纳米碳纤维与CaP聚合物自组装,制备的最终稳定、光热转化率高的光热试剂,具体方法如下:
将步骤B中表面氨基化的多孔纳米碳纤维通过层层自组装与钙磷复合。在磁力搅拌下,向10mL的去离子水中加入5mg的Ca(OH)2和100μL的PAA溶液(0.1g/mL-0.3g/mL),然后取表面改性后的多孔纳米碳纤维形成的水溶液 5mL加入上述溶液中,缓慢滴加20mL的IPA,再加入15mg磷酸氢二钠,室温搅拌8-12h,离心后用氨水和去离子水离心清洗多次、冻干,获得最终具有增强肿瘤治疗效果的多孔纳米碳纤维复合钙磷光热试剂。
优选的,所述多孔纳米碳纤维来源包括聚丙烯腈碳纤维、沥青基碳纤维、粘胶基碳纤维、酚醛基碳纤维、气相生长碳纤维中的一种或多种混合物。
优选的,所述多孔纳米碳纤维的粒径为10-800nm,长度为100-500nm。
优选的,所述多孔纳米碳纤维与CaP的复合比例为1-3:1;具体步骤为:向聚丙烯酸溶液中依次加入钙离子,表面改性后的纳米碳纤维,异丙醇和磷元素,室温搅拌8-12h,去离子水离心清洗多次,备用;钙源包括但不限于硝酸钙,氯化钙、氢氧化钙,磷源包括但不限于磷酸氢二钠,磷酸二氢钠,磷酸二氢钾。
优选的,在低PH环境或近红外激光的照射下,都能够促进所述光热试剂包覆的CaP中Ca2+的释放;Ca2+进入肿瘤细胞后破坏线粒体中钙离子的稳态,从而使细胞凋亡。
优选的,当所述光热试剂分散液浓度小于400μg/mL时,细胞存活率高于80%;当所述光热试剂分散液的浓度在50μg/mL-400μg/mL时,在波长为 808nm的近红外激光照射下5min,温度可由室温升高到35℃-70℃;将所述光热试剂分散在细胞培养液中,浓度为50μg/mL-400μg/mL时,肿瘤抑制率达 85%。
优选的,一种钙磷复合多孔纳米碳纤维光热试剂,光热试剂分散液的浓度在50μg/mL-400μg/mL时,在波长为808nm的近红外激光照射下5min,温度可由室温升高到35℃-70℃,在近红外的照射和肿瘤酸性环境下Ca2+的释放浓度达80%-100%,在光热治疗与Ca2+的的协同作用下肿瘤抑制率可达85%。
与现有技术相比,本发明的有益效果是:本发明制备了稳定、光热转化效率高的光热试剂,具有优良的生物相容性和分散性,其吸收波长范围在 700nm-1100nm,浓度为200μg/mL时,在波长为808nm的近红外激光照射下 5min,温度可由室温升高到35℃-70℃,在近红外的照射和肿瘤酸性环境下 Ca2+的释放浓度达80%-100%,在光热治疗与Ca2+的的协同作用下肿瘤抑制率 70%-85%;本发明以环保无污染为原则,使用原料来源广,采用静电纺丝技术制备多孔纳米碳纤维,纳米碳纤维的粒径易于控制,最终产品的生物相容性好,分散性好,光热转化性优良。
附图说明
图1为本发明扫描电镜图。
图2为在功率2W的808nm近红外照射下,不同浓度的光热试剂的升温曲线。
具体实施方式
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
请参阅图1-2,本发明提供一种技术方案:一种钙磷复合多孔纳米碳纤维光热试剂的制备方法,包括以下步骤:
A、采用静电纺技术制备多孔纳米碳纤维;
B、对纳米碳纤维进行表面改性时,先用浓硫酸和硝酸混合液酸化,再进行酰胺化处理;进一步提高纳米碳纤维的生物相容性和分散性;
C、表面氨基化的纳米碳纤维与CaP聚合物自组装,制备的最终稳定、光热转化率高的光热试剂。
步骤A具体操作如下:
采用静电纺技术制备多孔纳米碳纤维。首先,按照质量分数分别为7%-50%的聚丙烯腈(PAN),5%-10%的聚甲基丙烯酸甲酯(PMMA),40%-88%的二甲基甲酰胺(DMF)为基材配置纺丝溶液,60-80℃下搅拌溶融至溶液混合均匀后,进行纺丝。根据溶液的粘稠度设置不同的工艺参数,如纺丝速度 0.010mL/min-0.020mL/min,纺丝喷头到接受面的距离10-20cm等。
然后,将纺出的薄膜先在230-260℃环境中进行预氧化,再在700-900℃中碳化,整个过程在氮气环境中进行。将碳化后形成的多孔纳米碳纤维研磨成粉末状备用。
其中,多孔纳米碳纤维来源包括聚丙烯腈碳纤维、沥青基碳纤维、粘胶基碳纤维、酚醛基碳纤维、气相生长碳纤维中的一种或多种混合物;多孔纳米碳纤维的粒径为10-800nm,长度为100-500nm。
步骤B具体操作方法如下:
将步骤A中的多孔纳米碳纤维浸没在浓硫酸和浓硝酸(3:1)的混合液中, 60-80℃下搅拌3-5h。然后以6800-7830rpm转速离心,清洗多次,冻干。将冻干后的多孔纳米碳纤维进行氨基化处理。所述纳米碳纤维表面氨基化有如下制备方法:
1)按纳米碳纤维与PEG以1:10-30的质量比混合均匀,溶于去离子水中,再依次加入DMAP和DCC,60-80℃反应24h,离心清洗,冻干备用。
2)按纳米碳纤维与硫脲1:5-10的质量比混合均匀,放入管式碳化炉中氮气环境下80℃反应30-60min,100℃保温30min,130-178℃反应2-4h,降至室温离心清洗,冻干备用。
3)将CTAB和NaOH溶解在去离子水中,70-90℃搅拌1-2h,加入多孔纳米碳纤维、缓慢滴加TEOS和硅烷偶联剂KH550,80℃下搅拌1-3h,离心清洗,分散在稀盐酸溶液中,搅拌24h,再次离心清洗,冻干备用。
步骤C具体操作 方法如下:
将步骤B中表面氨基化的多孔纳米碳纤维通过层层自组装与钙磷复合。在磁力搅拌下,向10mL的去离子水中加入5mg的Ca(OH)2和100μL的PAA溶液(0.1g/mL-0.3g/mL),然后取表面改性后的多孔纳米碳纤维形成的水溶液 5mL加入上述溶液中,缓慢滴加20mL的IPA,再加入15mg磷酸氢二钠(Na2HPO4),室温搅拌8-12h,离心后用氨水和去离子水离心清洗多次、冻干,获得最终具有增强肿瘤治疗效果的多孔纳米碳纤维复合钙磷光热试剂。
在低PH环境或近红外激光的照射下,都能够促进所述光热试剂包覆的CaP 中Ca2+的释放;Ca2+进入肿瘤细胞后破坏线粒体中钙离子的稳态,从而使细胞凋亡。
本发明制备了稳定、光热转化效率高的光热试剂,具有优良的生物相容性和分散性,其吸收波长范围在700nm-1100nm,浓度为200μg/mL时,在波长为808nm的近红外激光照射下5min,温度可由室温升高到35℃-70℃,在近红外的照射和肿瘤酸性环境下Ca2+的释放浓度达80%-100%,在光热治疗与 Ca2+的的协同作用下肿瘤抑制率70%-85%;本发明以环保无污染为原则,使用原料来源广,采用静电纺丝技术制备多孔纳米碳纤维,纳米碳纤维的粒径易于控制,最终产品的生物相容性好,分散性好,光热转化性优良。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (6)
1.一种钙磷复合多孔纳米碳纤维光热试剂的制备方法,其特征在于:包括以下步骤:
A、采用静电纺技术制备多孔纳米碳纤维:
首先,按照质量分数分别为7%-50%的聚丙烯腈,5%-10%的聚甲基丙烯酸甲酯,40%-88%的二甲基甲酰胺为基材配置纺丝溶液,60-80℃下搅拌溶融至溶液混合均匀后,进行纺丝,根据溶液的粘稠度设置不同的工艺参数,纺丝速度0.010mL/min-0.020mL/min,纺丝喷头到接受面的距离10-20cm;
然后,将纺出的薄膜先在230-260℃环境中进行预氧化,再在700-900℃中碳化,整个过程在氮气环境中进行,将碳化后形成的多孔纳米碳纤维研磨成粉末状备用;
B、对纳米碳纤维进行表面改性时,先用浓硫酸和硝酸混合液酸化,再进行酰胺化处理;进一步提高纳米碳纤维的生物相容性和分散性,具体方法如下:
将步骤A中的多孔纳米碳纤维浸没在浓硫酸和浓硝酸3:1的混合液中,60-80℃下搅拌3-5h;然后以6800-7830rpm转速离心,清洗多次,冻干;将冻干后的多孔纳米碳纤维进行氨基化处理;所述纳米碳纤维表面氨基化有如下制备方法:
1)按纳米碳纤维与PEG以1:10-30的质量比混合均匀,溶于去离子水中,再依次加入DMAP和DCC,60-80℃反应24h,离心清洗,冻干备用;
2)按纳米碳纤维与硫脲1:5-10的质量比混合均匀,放入管式碳化炉中氮气环境下80℃反应30-60min,100℃保温30min,130-178℃反应2-4h,降至室温离心清洗,冻干备用;
3)将CTAB和NaOH溶解在去离子水中,70-90℃搅拌1-2h,加入多孔纳米碳纤维、缓慢滴加TEOS和硅烷偶联剂KH550,80℃下搅拌1-3h,离心清洗,分散在稀盐酸溶液中,搅拌24h,再次离心清洗,冻干备用;
C、表面氨基化的纳米碳纤维与CaP聚合物自组装,制备得最终稳定、光热转化率高的光热试剂,具体方法如下:
将步骤B中表面氨基化的多孔纳米碳纤维通过层层自组装与钙磷复合,在磁力搅拌下,向10mL的去离子水中加入5mg的Ca(OH)2和100μL的PAA溶液0.1g/mL-0.3g/mL,然后取表面改性后的多孔纳米碳纤维形成的水溶液5mL加入上述溶液中,缓慢滴加20mL的IPA,再加入15mg磷酸氢二钠,室温搅拌8-12h,离心后用氨水和去离子水离心清洗多次、冻干,获得最终具有增强肿瘤治疗效果的多孔纳米碳纤维复合钙磷光热试剂。
2.根据权利要求1所述的一种钙磷复合多孔纳米碳纤维光热试剂的制备方法,其特征在于:所述多孔纳米碳纤维的粒径为10-800nm,长度为100-500nm。
3.根据权利要求1所述的一种钙磷复合多孔纳米碳纤维光热试剂的制备方法,其特征在于:在低PH环境或近红外激光的照射下,都能够促进所述光热试剂包覆的CaP中Ca2+的释放;Ca2+进入肿瘤细胞后破坏线粒体中钙离子的稳态,从而使细胞凋亡。
4.根据权利要求1所述的一种钙磷复合多孔纳米碳纤维光热试剂的制备方法,其特征在于:当所述光热试剂分散液浓度小于400μg/mL时,细胞存活率高于80%;当所述光热试剂分散液的浓度在50μg/mL-400μg/mL时,在波长为808nm的近红外激光照射下5min,温度可由室温升高到35℃-70℃;将所述光热试剂分散在细胞培养液中,浓度为50μg/mL-400μg/mL时,肿瘤抑制率达85%。
5.根据权利要求4所述的一种钙磷复合多孔纳米碳纤维光热试剂的制备方法,其特征在于:所述光热试剂的分散液为去离子水,磷酸缓冲溶液,细胞培养液或血清,所述光热试剂在分散液中都有很好的分散性,放置一周没有明显沉淀现象。
6.采用如权利要求1-5任一项所述的制备方法制得的一种钙磷复合多孔纳米碳纤维光热试剂,其特征在于:光热试剂分散液的浓度在50μg/mL-400μg/mL时,在波长为808nm的近红外激光照射下5min,温度可由室温升高到35℃-70℃,在近红外的照射和肿瘤酸性环境下Ca2+的释放浓度达80%-100%,在光热治疗与Ca2+的协同作用下肿瘤抑制率可达85%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010114673.5A CN111228490B (zh) | 2020-02-25 | 2020-02-25 | 一种钙磷复合多孔纳米碳纤维光热试剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010114673.5A CN111228490B (zh) | 2020-02-25 | 2020-02-25 | 一种钙磷复合多孔纳米碳纤维光热试剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111228490A CN111228490A (zh) | 2020-06-05 |
CN111228490B true CN111228490B (zh) | 2022-04-08 |
Family
ID=70876645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010114673.5A Active CN111228490B (zh) | 2020-02-25 | 2020-02-25 | 一种钙磷复合多孔纳米碳纤维光热试剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111228490B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114848512B (zh) * | 2022-05-09 | 2024-04-09 | 南通大学 | 一种基于红外驱动的自发热面膜及其生产工艺 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102199368A (zh) * | 2010-03-23 | 2011-09-28 | 西南交通大学 | 一种通过原位沉积磷酸钙对碳纳米管进行功能改性的方法 |
CN107261142A (zh) * | 2017-06-05 | 2017-10-20 | 东华大学 | 一种用于肿瘤治疗的多孔纳米碳纤维基载药光热试剂及其制备方法 |
CN108079383A (zh) * | 2017-12-29 | 2018-05-29 | 广州军区广州总医院 | 一种光热抗肿瘤壳聚糖-纳米羟基磷灰石-碳量子点支架、其制备方法及应用 |
-
2020
- 2020-02-25 CN CN202010114673.5A patent/CN111228490B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102199368A (zh) * | 2010-03-23 | 2011-09-28 | 西南交通大学 | 一种通过原位沉积磷酸钙对碳纳米管进行功能改性的方法 |
CN107261142A (zh) * | 2017-06-05 | 2017-10-20 | 东华大学 | 一种用于肿瘤治疗的多孔纳米碳纤维基载药光热试剂及其制备方法 |
CN108079383A (zh) * | 2017-12-29 | 2018-05-29 | 广州军区广州总医院 | 一种光热抗肿瘤壳聚糖-纳米羟基磷灰石-碳量子点支架、其制备方法及应用 |
Non-Patent Citations (2)
Title |
---|
Near-infrared light and pH-responsive Au@carbon/calcium phosphate nanoparticles for imaging and chemo-photothermal cancer therapy of cancer cells;Huiyuan Wang等;《Dalton Trans》;20171231;第46卷;第14746-14751页 * |
碳纤维的表面改性及羟基磷灰石涂层的制备;张黎等;《陕西科技大学学报》;20171031;第35卷(第5期);第77-81页 * |
Also Published As
Publication number | Publication date |
---|---|
CN111228490A (zh) | 2020-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wentao et al. | Functionalization of polyvinyl alcohol composite film wrapped in am-ZnO@ CuO@ Au nanoparticles for antibacterial application and wound healing | |
Zhao et al. | Silver nanoparticle-modified 2D MOF nanosheets for photothermally enhanced silver ion release antibacterial treatment | |
CN106267204B (zh) | 一种黑磷纳米片-抗肿瘤化合物的复合材料及其制备方法和应用 | |
Xue et al. | Scalable fabrication of polydopamine nanotubes based on curcumin crystals | |
CN107261142B (zh) | 一种用于肿瘤治疗的多孔纳米碳纤维基载药光热试剂及其制备方法 | |
Du et al. | NIR-activated multi-hit therapeutic Ag2S quantum dot-based hydrogel for healing of bacteria-infected wounds | |
Ding et al. | Photothermal nanohybrid hydrogels for biomedical applications | |
Hui et al. | ICG@ ZIF-8/PDA/Ag composites as chemo-photothermal antibacterial agents for efficient sterilization and enhanced wound disinfection | |
CN111375060B (zh) | 具有pH和近红外光响应药物释放的复合纤维及其制备方法与应用 | |
CN111228484B (zh) | 铜硅钙石的应用以及含有铜硅钙石的复合生物材料 | |
CN113751079B (zh) | 一种生物材料负载的钙钛矿-二氧化钛纳米复合光催化剂及其构建方法和应用 | |
CN111228490B (zh) | 一种钙磷复合多孔纳米碳纤维光热试剂的制备方法 | |
WO2022007298A1 (zh) | 一种具有快速粘液渗透作用的复合纳米微球及其制备方法和应用 | |
Farshidfar et al. | Carbon dots with tissue engineering and regenerative medicine applications | |
CN114344544A (zh) | 光激活抗菌敷料及其制备方法 | |
Zhang et al. | Engineering of near-infrared-activated lignin–Polydopamine–Nanosilver composites for highly efficient sterilization | |
Ye et al. | MXene: A wonderful nanomaterial in antibacterial | |
Zhang et al. | Green and rapid synthesis of cysteine-directed novel AgCu nanocluster hydrogel with good antibacterial activity | |
CN116271029B (zh) | 一种具有强细菌吸附及光热性能生物制剂及其应用 | |
CN106310263B (zh) | 一种PEGMa修饰MoOx与温敏PNIPAM微凝胶的组装体系及其制备方法 | |
Li et al. | Gold nanocluster decorated fibrous substrate for photo-modulated cellular growth | |
Venkatesan et al. | Preparation and photothermal effect of Chitosan-Alginate-Molybdenum diselenide nanocomposite scaffolds for cancer therapy | |
Liang et al. | Facile synthesis of phycocyanin/polydopamine hierarchical nanocomposites for synergizing PTT/PDT against cancer | |
Enoch et al. | Enhancement of MXene optical properties towards medical applications via metal oxide incorporation | |
CN111514315B (zh) | 一种肿瘤靶向无定形磷酸钙荧光纳米复合材料负载药物的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |